University of California, San Francisco (UCSF)

603 articles with University of California, San Francisco (UCSF)

• 

  Long-Standing Cancer Institute Shutters Its Doors

  8/1/2018

  The Cancer Prevention Institute of California (CPIC), located in Fremont, California, announced it was disbanding after 44 years. The reason for the closing, it indicates, is lack of federal funding.

• Liver Fix Thyself

  5/2/2018

  By studying a rare liver disease called Alagille syndrome, scientists from Cincinnati Children's and the University of California San Francisco (UCSF) have discovered the mechanism behind an unusual form of tissue regeneration that may someday reduce the need for expensive and difficult-to-obtain organ transplants.

• Automated Breast Density from Volpara Solutions Strongly Predicts Risk of Screen-Detected and Interval Cancers

  5/1/2018

  Research from University of California San Francisco and the Mayo Clinic Supports the Use of Fully Automated Volpara®Density™ Software to Inform Women of their Breast Density

• Enamine Expands Collaboration with UCSF to Explore Synthetically Feasible Chemical Space

  1/25/2018

  Enamine today announced that it has expanded its collaboration on ZINC, a comprehensive online database of purchasable compounds curated by the Irwin and Shoichet laboratories in the Department of Pharmaceutical Chemistry at the University of California, San Francisco (UCSF).

• Midatech and UCSF Receive IND Approval for DIPG Treatment MTX110

  1/16/2018

  The study will be conducted at leading treatment centres in UCSF in San Francisco, and the Memorial Sloan Kettering Cancer Center in New York

• Apexigen Announces New Collaboration With UCSF

  10/25/2017

  Apexigen today announced the initiation of patient enrollment in a Phase II clinical trial in collaboration with the UCSF.

• Strata Oncology Announces Partnership With UCSF To Launch Stratify Prostate Initiative To Expand Access To Precision Medicine Clinical Trials For 10,000 Men With Metastatic Prostate Cancer

  10/4/2017

• Novartis AG Lures Superstar Scientist Away From UCSF

  8/17/2017

• Approval of Medical Device Changes Often Based On Low-Quality Research, UCSF and Yale University School Of Medicine Study

  8/17/2017

• Two Pore Guys Announces Positive Results From Pilot Point-Of-Care Liquid Biopsy Study With UCSF

  8/16/2017

• ShangPharma Innovation And The UCSF Announce Strategic Research Collaboration

  7/13/2017

• UCSF Enhances Cancer Assay With Interpretive Reporting Powered By GenomOncology’s GO Clinical Workbench

  6/27/2017

• Xynomic Pharma And UCSF Entered Strategic Partnership In Conducting A Phase II/III Trial Of Abexinostat Against Renal Cell Carcinoma

  5/22/2017

• Vanda And UCSF Announce License Agreement For CFTR Activators And Inhibitors

  3/30/2017

• UCSF Heart Doctor Wary of Amgen-Paid Repatha Study

  3/23/2017

• New Test May Predict Onset Of Alzheimer's, UCSF Study Reveals

  3/22/2017

• MIODx Licenses Key Immunotherapy Technologies From UCSF

  2/23/2017

• Caladrius Biosciences Release: Biotech Announces Addition Of Three Clinical Sites, Including UCSF, For The Ongoing Phase 2 Study Of CLBS03 In T1D

  1/25/2017

• UCSF Release: University First To Adopt Endomag's Magseed As Standard Of Care For

  1/23/2017

• Two Pore Guys And UCSF Collaborate On Liquid Biopsy Study With First Handheld Device For Cancer Monitoring

  1/6/2017